| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.63B | +5.4% | +25.1% |
| Cost of Revenue | $1.20B | +3.7% | +22.2% |
| Gross Profit | $432.0M | +10.2% | +34.2% |
| R&D Expense | $102.0M | +12.1% | +14.6% |
| SG&A Expense | $102.0M | +29.1% | +27.5% |
| Operating Income | $84.0M | +5.0% | +147.1% |
| Pre-tax Income | $104.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.36B | +13.7% | +78.3% |
| Accounts Receivable | $121.0M | +0.0% | +15.2% |
| Inventory | $104.0M | +1.0% | -1.9% |
| Current Assets | $2.50B | +7.7% | +38.5% |
| Total Assets | $2.97B | +7.4% | +33.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $467.0M | — | — |
| Investing Cash Flow | -$20.0M | — | — |
| Financing Cash Flow | $70.0M | — | — |
| +25.3% |
| +82.5% |
| Income Tax | -$1.0M | -133.3% | -200.0% |
| Net Income | $105.0M | +31.3% | +87.5% |
| EPS (Basic) | $0.18 | +28.6% | +80.0% |
| EPS (Diluted) | $0.16 | +23.1% | +128.6% |
| $911.0M |
| +1.9% |
| +21.8% |
| Total Liabilities | $957.0M | +0.8% | +18.6% |
| Stockholders' Equity | $2.01B | +10.8% | +41.8% |